Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China
- PMID: 16791018
- PMCID: PMC2749723
- DOI: 10.1097/01.aids.0000233577.33973.fa
Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China
Abstract
Background: Illegal commercial plasma donation in the late 1980s and early 1990s caused blood-borne infections in China.
Objectives: To estimate the prevalence of HIV and hepatitis C virus (HCV) infections and to identify associated risk factors in central China with a history of illegal plasma collection activities.
Design and methods: A cross-sectional study was carried out in 2004, in which all adult residents in four villages in rural Shanxi Province were invited for a questionnaire interview and testing of HIV and HCV antibodies.
Results: Of 3062 participating villagers, 29.5% reported a history of selling whole blood or plasma. HIV seropositivity was confirmed in 1.3% of subjects and 12.7% were HCV positive. Their co-infection rates were 1.1% among all study subjects, 85% among HIV-positive subjects, and 8.7% among HCV-positive subjects. Selling plasma [odds ratio (OR), 22.5; 95% confidence interval (CI), 16.1-31.7; P < 0.001] or blood (OR, 3.1; 95% CI, 2.3-4.2; P < 0.001) were independently associated with HIV and/or HCV infections. Although a spouse's history of selling plasma/blood was not associated with either infection, the HIV or HCV seropositivity of a spouse was significantly associated with HIV and/or HCV infections (both OR, 3.2; 95% CI, 2.0-5.2 in men, 2.0-4.9 in women; P < 0.001). For men, residence in the village with a prior illegal plasma collection center (OR, 2.5; 95% CI, 1.7-3.7; P < 0.001) and for women, older age (OR, 3.4; 95% CI, 1.2-14.0; P = 0.04) were associated with HIV and/or HCV infections.
Conclusions: HIV and HCV infections are now prevalent in these Chinese communities. HIV projects should consider screening and care for HCV co-infection.
Comment in
-
The legacy of unhygienic plasma collection in China.AIDS. 2006 Jun 26;20(10):1451-2. doi: 10.1097/01.aids.0000233580.56844.c1. AIDS. 2006. PMID: 16791021 No abstract available.
Similar articles
-
Hepatitis C virus infection in former commercial plasma/blood donors in rural Shanxi Province, China: the China Integrated Programs for Research on AIDS.J Infect Dis. 2005 Nov 15;192(10):1694-700. doi: 10.1086/497148. Epub 2005 Oct 6. J Infect Dis. 2005. PMID: 16235166 Free PMC article.
-
Prevalence of human herpesvirus 8 and hepatitis C virus in a rural community with a high risk for blood-borne infections in central China.Clin Microbiol Infect. 2011 Mar;17(3):395-401. doi: 10.1111/j.1469-0691.2010.03287.x. Clin Microbiol Infect. 2011. PMID: 20545961 Free PMC article.
-
Prevalence and risk factors of hepatitis C among former blood donors in rural China.Int J Infect Dis. 2012 Oct;16(10):e731-4. doi: 10.1016/j.ijid.2012.05.1035. Epub 2012 Jul 15. Int J Infect Dis. 2012. PMID: 22796320
-
HIV, HCV, and HBV co-infections in a rural area of Shanxi province with a history of commercial blood donation.Biomed Environ Sci. 2011 Jun;24(3):207-13. doi: 10.3967/0895-3988.2011.03.001. Biomed Environ Sci. 2011. PMID: 21784304
-
[A cross-sectional survey on hepatitis C virus infection among residents aged 18-59 years in a former commercial blood donating community, Shanxi Province].Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Nov;26(11):864-7. Zhonghua Liu Xing Bing Xue Za Zhi. 2005. PMID: 16676606 Chinese.
Cited by
-
Current Therapies in Clinical Trials of Parkinson's Disease: A 2021 Update.Pharmaceuticals (Basel). 2021 Jul 25;14(8):717. doi: 10.3390/ph14080717. Pharmaceuticals (Basel). 2021. PMID: 34451813 Free PMC article. Review.
-
Trends in notifiable infectious diseases in China: implications for surveillance and population health policy.PLoS One. 2012;7(2):e31076. doi: 10.1371/journal.pone.0031076. Epub 2012 Feb 16. PLoS One. 2012. PMID: 22359565 Free PMC article.
-
Short communication: emerging transmitted HIV type 1 drug resistance mutations among patients prior to start of first-line antiretroviral therapy in middle and low prevalence sites in China.AIDS Res Hum Retroviruses. 2012 Dec;28(12):1637-9. doi: 10.1089/aid.2012.0164. Epub 2012 Aug 27. AIDS Res Hum Retroviruses. 2012. PMID: 22822770 Free PMC article.
-
History of the HIV Epidemic in China.Curr HIV/AIDS Rep. 2019 Dec;16(6):458-466. doi: 10.1007/s11904-019-00471-4. Curr HIV/AIDS Rep. 2019. PMID: 31773405 Free PMC article. Review.
-
Risk of liver-associated morbidity and mortality in a cohort of HIV and HBV coinfected Han Chinese.Infection. 2011 Oct;39(5):427-31. doi: 10.1007/s15010-011-0145-1. Epub 2011 Jun 29. Infection. 2011. PMID: 21713428
References
-
- Sun YD, Meng ZD, Wang SY, Chen XR, Sun DG, Chen Z, et al. Epidemiologic investigation on an outbreak of hepatitis C. Chin Med J (Engl) 1991;104:975–979. - PubMed
-
- Wang S, Ding H, Zhang H. Hepatitis C virus infection among the plasmapheresis donors [in Chinese] Zhonghua Liu Xing Bing Xue Za Zhi. 1994;15:71–73. - PubMed
-
- Wu Z, Rou K, Detels D. Prevalence of HIV infection among former commercial plasma donors in rural eastern China. Health Policy Plan. 2001;16:41–46. - PubMed
-
- Zhang YX. The prevalence of HCV, HIV and HBV among paid blood donors [in Chinese] Lin Chuan Nei Ke Za Zhi. 2001;18:308–309.
-
- Sun Y. Epidemiological and serological study on hepatitis C virus infection in plasmapheresis donors [in Chinese] Zhonghua Liu Xing Bing Xue Za Zhi. 1991;12:327–330. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical